Jeffrey J. Brown - Nov 8, 2021 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Nov 8, 2021
Transactions value $
$973,911
Form type
4
Date filed
11/10/2021, 08:17 PM
Previous filing
Oct 20, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Purchase $43.7K +200 +0.65% $218.49 31K Nov 8, 2021 By Brown Equity Partners, LLC F1, F11
transaction MED Common Stock Purchase $36K +160 +0.52% $224.96 31.1K Nov 8, 2021 By Brown Equity Partners, LLC F2, F11
transaction MED Common Stock Purchase $45.3K +200 +0.64% $226.68 31.3K Nov 8, 2021 By Brown Equity Partners, LLC F3, F11
transaction MED Common Stock Purchase $45.6K +200 +0.64% $227.78 31.5K Nov 8, 2021 By Brown Equity Partners, LLC F4, F11
transaction MED Common Stock Purchase $66.7K +290 +0.92% $229.91 31.8K Nov 8, 2021 By Brown Equity Partners, LLC F5, F11
transaction MED Common Stock Purchase $34.7K +150 +0.47% $231.65 32K Nov 8, 2021 By Brown Equity Partners, LLC F6, F11
transaction MED Common Stock Purchase $188K +807 +2.53% $232.55 32.8K Nov 8, 2021 By Brown Equity Partners, LLC F7, F11
transaction MED Common Stock Purchase $139K +593 +1.81% $233.68 33.4K Nov 8, 2021 By Brown Equity Partners, LLC F8, F11
transaction MED Common Stock Purchase $235K +1K +3% $234.52 34.4K Nov 8, 2021 By Brown Equity Partners, LLC F9, F11
transaction MED Common Stock Purchase $141K +600 +1.75% $235.28 35K Nov 8, 2021 By Brown Equity Partners, LLC F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F2 This transaction was executed in multiple trades at prices ranging from $224.67 USD to $225.45 USD; the price reported above reflects the weighted average sale price.
F3 This transaction was executed in multiple trades at prices ranging from $226.51 USD to $226.85 USD; the price reported above reflects the weighted average sale price.
F4 This transaction was executed in multiple trades at prices ranging from $227.61 USD to $227.95 USD; the price reported above reflects the weighted average sale price.
F5 This transaction was executed in multiple trades at prices ranging from $229.75 USD to $230.13 USD; the price reported above reflects the weighted average sale price.
F6 This transaction was executed in multiple trades at prices ranging from $231.57 USD to $231.82 USD; the price reported above reflects the weighted average sale price.
F7 This transaction was executed in multiple trades at prices ranging from $232.00 USD to $232.99 USD; the price reported above reflects the weighted average sale price.
F8 This transaction was executed in multiple trades at prices ranging from $233.12 USD to $233.96 USD; the price reported above reflects the weighted average sale price.
F9 This transaction was executed in multiple trades at prices ranging from $234.11 USD to $234.99 USD; the price reported above reflects the weighted average sale price.
F10 This transaction was executed in multiple trades at prices ranging from $235.00 USD to $235.71 USD; the price reported above reflects the weighted average sale price.
F11 These shares are directly owned by Brown Equity Partners, LLC, for which the reporting person is the managing member.